- Home
- XGN vs MRCC Comparison
XGN vs MRCC Comparison
Compare XGN & MRCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XGN
- MRCC
- Stock Information
- Founded
- XGN 2002
- MRCC 2011
- Country
- XGN United States
- MRCC United States
- Employees
- XGN N/A
- MRCC N/A
- Industry
- XGN Medical Specialities
- MRCC Investment Managers
- Sector
- XGN Health Care
- MRCC Finance
- Exchange
- XGN Nasdaq
- MRCC Nasdaq
- Market Cap
- XGN 138.3M
- MRCC 137.1M
- IPO Year
- XGN 2019
- MRCC 2012
- Fundamental
- Price
- XGN $7.27
- MRCC $6.21
- Analyst Decision
- XGN Strong Buy
- MRCC Hold
- Analyst Count
- XGN 3
- MRCC 1
- Target Price
- XGN $9.00
- MRCC $8.00
- AVG Volume (30 Days)
- XGN 272.4K
- MRCC 100.0K
- Earning Date
- XGN 07-29-2025
- MRCC 08-06-2025
- Dividend Yield
- XGN N/A
- MRCC 16.10%
- EPS Growth
- XGN N/A
- MRCC 3301.50
- EPS
- XGN N/A
- MRCC 0.32
- Revenue
- XGN $56,724,000.00
- MRCC $56,983,000.00
- Revenue This Year
- XGN $18.92
- MRCC N/A
- Revenue Next Year
- XGN $14.78
- MRCC N/A
- P/E Ratio
- XGN N/A
- MRCC $19.11
- Revenue Growth
- XGN 1.78
- MRCC N/A
- 52 Week Low
- XGN $1.78
- MRCC $5.96
- 52 Week High
- XGN $7.95
- MRCC $8.85
- Technical
- Relative Strength Index (RSI)
- XGN 56.94
- MRCC 40.07
- Support Level
- XGN $6.81
- MRCC $6.22
- Resistance Level
- XGN $7.50
- MRCC $6.38
- Average True Range (ATR)
- XGN 0.33
- MRCC 0.13
- MACD
- XGN 0.02
- MRCC -0.01
- Stochastic Oscillator
- XGN 75.27
- MRCC 46.73
About XGN Exagen Inc.
Exagen Inc is a commercial-stage diagnostics company committed to addressing the unmet need for the accurate diagnosis and monitoring of patients affected by autoimmune rheumatic diseases. It currently markets ten testing products under its Avise brand to provide an accurate, timely, and differential diagnosis and to optimize the treatment of ARDs. It markets and sells solutions to community rheumatologists.
About MRCC Monroe Capital Corporation
Monroe Capital Corp is a speciality finance company focused on providing financing to lower middle-market companies, in the U.S. and Canada. The company provides customized financing solutions focused on senior, unitranche, and junior secured debt and unsecured subordinated debt and equity, including equity co-investments in preferred and common stock and warrants.